INTRODUCTION
CD44 is a family of cell-surface glycoproteins, encoded by a single complex gene. In the adult animal, the CD44 antigen is expressed by many cell types: hematolymphoid cells; several types of epithelia; and a variety of mesenchymal tissues, including fibroblasts, smooth muscle cells, and astrocytes (Trowbridge et al., 1982; Flanagan et al., 1989; Picker et al., 1989; Kennel et al., 1993) . The extracellular, N-terminal part of the CD44 molecule, whose molecular mass is 85-90 kD, comprises a binding site for hyaluronic acid (HA).
Some forms of the CD44 antigen can also be associated with chondroitin sulfate to yield a protein of 180-200 kD. CD44 is implicated in cell-cell and cell-substrate adhesion. It can bind several ligands such as collagen and fibronectin, which are important components of extracellular matrixes (ECM) (Carter and Wagner, 1988; Jalkanen and Jalkanen, 1992) . In addition, CD44 was found to be a major receptor for hyaluronate (HA) (Aruffo et al., 1990; Lesley et al., 1990; Miyake et al., 1990b ). Many functions have been attributed to "Corresponding author. CD44 molecules, relating to T-cell and B-cell ontogeny (Hyman et al., 1986; Miyake et al., 1990a) , cell activation (Budd et al., 1987; Tabi et al., 1988, Mobley and Dailey, 1992) , lymphocyte extravasation across endothelial barriers (reviewed by Berg et al., 1989) , degradation of HA (reviewed by Underhill, 1992) , and tumor metastasis .
In addition to the "standard" form of CD44 , an increasing number of variant CD44 molecules have been described that result from the insertion of any of ten additional variant (v) exons, labeled vl to v l0, alternatively spliced in the extracellular/membrane-proximal domain Jackson et al., 1992; Screaton et al., 1992; Tolg et al., 1993) . Among these variants, the p-meta-1 variant , con- taining the variable exons v4 to v7, has been implicated in the metastatic spread of tumors. Interestingly, a close variant containing the unique additional exon v6 is induced upon lymphocyte activation in vivo and appears to function as a homing receptor for lymphocyte entry into lymph nodes (Arch et al., 1992 (Doetschman etal., 1985 (Doetschman etal., , 1987 (Martin, 1981; Doestschman et al., 1985 Doestschman et al., , 1987 can be detected after 7 days in both differentiation culture conditions. At this stage, the mRNA pattern of CD44 has been considerably modified: 4.5-kb band, which is predominant in cells such as thymocytes, a T-cell hybridoma, and astrocytes (Haegel and Ceredig, 1991; Haegel etal., 1993) (Maniatis et al., 1982) , and separated according to size on a 1% agarose formaldehyde gel that was blotted onto a Hybond-N nylon filter (Amersham, les Ulis, France).
The amount and quality of the loaded material was checked by methylene blue staining of the filters (Maniatis etal., 1982 (Fig. 1, right panel) . The amount of RNA loaded on Northern blots was checked by methylene blue staining of the filters, and ribosomal RNA bands were used as size markers (Fig. 1, lower  panel) . Two bands were shown to hybridize to a CD44 cDNA probe . Their sizes were estimated to be 1.6 and 3.3 kb. They were compared to the CD44 mRNA pattern of a T-cell hybridoma, Hl1.1 (Fig. 1, left panel) , known to express a high level of CD44 protein on the cell surface and to contain transcripts of 1.6, 3.5, and 4.5 kb (Haegel and Ceredig, 1991) . The difference in size between CD44 mRNA has been proposed to result from distinct polyadenylation sites or 3'UTR length (Schtivelman and Bishop, 1991 (Fig. 2A) . Note that compared to the D3 cells used in Fig. 1 , those in Fig. 2A (left panel) presented a faint additional mRNA band slightly smaller than the 1.6 kb species. This difference may correspond to the later passage number of cells used in Fig. 2A . Upon differentiation, not only did the bands corresponding to the 3.3-and 1.6-kb mRNAs become more intense, but new mRNA species of 2.5, 3, and 4.5 kb appeared ( Fig. 2A, right  panel) . The 4.5-kb mRNA species corresponds to the predominant transcript found in mouse thymocytes, astrocytes (Haegel and Ceredig, 1991; Haegel et al., 1993) , and the Hl1.1 T-cell line (Fig. 1 Fig. 3 ) amplify the region located between v6 and 3' constant region, whereas A and C (lanes 2 and 5 in Fig. 3 (Fig. 3, upper right, lane 6 ). This product might result from the presence of an epithelial-type CD44 variant (Stamenkovic et al., 1991) , which contains exons v8 to vl0. However, hybridization to appropriate oligonucleotides would be required to clearly characterize this variant. In differentiated ES cells, we have not detected either the variant of CD44 containing exon v6 but not vl0, analogous to the v4-v7 variant p-meta-1 (Gfinthert et al., 1991) or the v6-only variant, known to be induced upon in vivo activation of lymphocytes (Arch et al., 1992) . The sequence of events occurring early in embryonic development can be followed in vitro by spontaneous differentiation of ES cells; several studies show that the simple embryoid bodies that have developed within 6 days are analogous to the 4.5-day blastocyst, with endodermal cells and innercell mass stem cells (Doetschman et al., 1985 (Doetschman et al., , 1987 . From day 6 to day in vitro, the embryoid bodies become complex as ectoderm like cells develop underneath basal lamina. This stage is related to day 5.5 of embryonic development. After 8 days in culture, complex embryoid bodies become cystic (CEBs) and appear analogous to the visceral yolk sac (days 9-10). CEBs contain cell types of mesodermal origin: a variety of hematopoietic cells such as erythroid cells, granulocytes, macrophages, pro-B and pro-T lymphoid progenitors develop in blood islands (Doetschman etal., 1985; Schmitt etal., 1991; Wiles and Keller, 1991; Chen, 1992; Guttierez-Ramos and Palacios, 1992; Keller et al., 1993) . Myocardium, endocardium, and neural cell types (Doetschman et al., 1987) (Lesley et al., 1985) . CD44-mediated cellcell interactions are essential for the development of mature lymphocytes, and bone marrow precursors need the CD44 molecule to migrate to the thymic microenvironment (Hyman etal., 1986 Screaton and colleagues (1992) . In the mouse, this splice donor site has not been demonstrated but it is possible that a splicing takes place in the s5 exon.
In a previous study, we found a correlation between CD44 surface expression and the presence of the 4.5 kb mRNA band on Northern blots of mouse thymocytes and T-cell hybridoma (Haegel and Ceredig, 1991 (Fig. 2B and not shown) . From the very low amount of variant CD44 transcripts, undetected on Northern blots using oligonucleotide probes to variable exons, it would seem that if efficiently expressed, these variants are quantitatively of minor importance compared to the "standard" CD44. An interesting characteristics of these variants is that they all seem to contain the vl0 exon, and at least two of them bear the v6 exon in addition (Fig. 3) . The longest appears to be similar to one CD44 variant isolated from the murine carcinoma line KLN205 (He et al., 1992 (Hofmann etal., 1991) . In contrast, their structure is clearly distinct from CD44 variants containing v6 but not v l0, a variant that can be induced notably by in vivo lymphocyte (Arch et al., 1992) or astrocyte (Haegel et al., 1993) activation and expressed on metastatic cell (G(inthert et al., 1991) . We conclude that these CD44 variants do not appear early during embryonic development. In contrast, variants containing v l0 in addition to v6 can be induced very early upon in vitro ES development.
Our results led us to speculate on the possible roles of CD44 in early embryonic development. Actin molecules, to which CD44 may be associated (Kalomiris and Bourguignon 1989) have been found concentrated at contact regions between differentiating blastomeres in the mouse preimplantation embryo (Slager etal., 1992 (Doetschman et al., 1987) . In addition, CD44 is known as the main ligand for hyaluronate (HA), which appears to be involved in embryo implantation on mouse endometrium (Brown and Papaioannou, 1992) . Moreover, the synthesis of collagen, a ligand for chondroitinsulfate-associated CD44, is enhanced upon decidualization (Aplin etal., 1988) . CD44 expression leading to HA degradation may allow morphological changes in the developing tissues (Underhill, 1992 
